Scientific techniques in adolescent and young adult classic Hodgkin lymphoma

Scientific techniques in adolescent and young adult classic Hodgkin lymphoma

Abstract Understanding the tumor microenvironment and genomic landscape is crucial for better prediction of treatment outcomes and developing novel therapies in Hodgkin lymphoma (HL). Recent advancements in genomics have enabled researchers to gain deeper insights into the genomic characteristics of...

Full description

Bibliographic Details
Main Authors:	Francesco Maura, Ragini M. Adams, Tomohiro Aoki
Format:	Article
Language:	English
Published:	Wiley 2023-11-01
Series:	eJHaem
Online Access:	https://doi.org/10.1002/jha2.786

Similar Items

Treatment of Hodgkin's lymphomas in adolescent and young adults
by: S. V. Semochkin, et al.
Published: (2022-11-01)

Comparative Effectiveness of Proton Therapy versus Photon Radiotherapy in Adolescents and Young Adults for Classical Hodgkin Lymphoma
by: James E. Bates, MD, et al.
Published: (2021-07-01)

Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1
by: Howland E. Crosswell, et al.
Published: (2023-10-01)

Genetics of classical Hodgkin Lymphoma
by: Gianluca Schiavoni, et al.
Published: (2018-06-01)

Composite follicular lymphoma and classic Hodgkin lymphoma
by: Han-Na Kim, et al.
Published: (2022-01-01)

Treatment of advanced Hodgkin lymphomas in adolescents and young adults: efficacy and toxicity issues
by: Yu. V. Larina, et al.
Published: (2014-07-01)

Treatment of advanced Hodgkin lymphomas in adolescents and young adults: efficacy and toxicity issues
by: Yu. V. Larina, et al.
Published: (2014-07-01)

The real risk of secondary non-Hodgkin lymphoma following classical Hodgkin lymphoma
by: Ahmet Dogan
Published: (2022-10-01)

Controversies in the Treatment of Classical Hodgkin Lymphoma
by: Dennis A. Eichenauer, et al.
Published: (2018-10-01)

Classical Hodgkin’s Lymphoma Presenting as Erythroderma
by: Kumar Parimalam, et al.
Published: (2022-11-01)

Development of classical Hodgkin’s lymphoma in an adult with biallelic STXBP2 mutations
by: Maciej Machaczka, et al.
Published: (2013-05-01)

Classical Hodgkin's lymphoma with cutaneous involvement in an adolescent male: A case study
by: Sumon Ghosh, et al.
Published: (2022-02-01)

Matrix metalloproteinase-9 expression by Hodgkin-Reed-Sternberg cells is associated with reduced overall survival in young adult patients with classical Hodgkin lymphoma.
by: Antonio Hugo Campos, et al.
Published: (2013-01-01)

Current directions in the treatment of classical Hodgkin lymphoma
by: Frank G. Keller, et al.
Published: (2023-11-01)

CAR-T Cell Therapy for Classical Hodgkin Lymphoma
by: Mikalai Katsin, et al.
Published: (2023-12-01)

Treatment Of Classical Hodgkin Lymphoma: The State Of The Art
by: Carmino Antonio de Souza, et al.
Published: (2023-10-01)

Bone marrow involvement by classic Hodgkin lymphoma
by: Mohammad Barouqa, et al.
Published: (2022-05-01)

Aberrant synaptophysin expression in classic Hodgkin lymphoma
by: Soyoung Im, et al.
Published: (2022-11-01)

Bob-1 is expressed in classic Hodgkin lymphoma
by: Abd El All Howayda S
Published: (2007-03-01)

Relapsed and refractory classical Hodgkin lymphoma immunotherapy
by: Kirill Lepik
Published: (2020-10-01)

Evolution of drug therapy for classical Hodgkin lymphoma
by: N. Y. Samaneva, et al.
Published: (2022-09-01)

CD4+ T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2: Characterizing CD4+ T cells in Hodgkin lymphoma
by: Johanna Veldman, et al.
Published: (2022-12-01)

Classical Hodgkin Lymphoma Presenting with Severe, Recurrent Hypothermic Episodes
by: Jonas Juul Hansen, et al.
Published: (2018-01-01)

Treatment outcomes in classic Hodgkin lymphoma: 5‐year update from the Brazilian Hodgkin Lymphoma Registry
by: Irene Biasoli, et al.
Published: (2023-11-01)

Classical Hodgkin’s lymphoma: the Lymphoma Study Association guidelines for relapsed and refractory adult patients eligible for transplant
by: Eric Van Den Neste, et al.
Published: (2013-08-01)

Classical Hodgkin lymphoma following follicular lymphoma: a case report
by: Bomi Kim
Published: (2023-11-01)

Case report: Composite mantle cell lymphoma and classical Hodgkin lymphoma
by: Hongyu Wang, et al.
Published: (2023-03-01)

The Management of Classical Hodgkin's Lymphoma: Past, Present, and Future
by: S. E. Richardson, et al.
Published: (2011-01-01)

Hemophagocytic Lymphohistiocytosis in a Patient with Classical Hodgkin Lymphoma
by: G. Hyun, et al.
Published: (2016-01-01)

Classic Hodgkin lymphoma-nodular sclerosis – case report
by: Mihaela Lebedenco, et al.
Published: (2023-06-01)

Optimization of the first line treatment in classical Hodgkin's lymphoma
by: Pauline Brice
Published: (2018-06-01)

Cell-Free DNA for the Management of Classical Hodgkin Lymphoma
by: Vincent Camus, et al.
Published: (2021-03-01)

The Evolving Role of Brentuximab Vedotin in Classical Hodgkin Lymphoma
by: Lai C, et al.
Published: (2019-12-01)

An updated portrait of monocyte-macrophages in classical Hodgkin lymphoma
by: Isacco Ferrarini, et al.
Published: (2023-02-01)

Mucocutaneous Paraneoplastic Syndrome Secondary to Classical Hodgkin’s Lymphoma
by: Jenna Jurkovic, et al.
Published: (2019-05-01)

686 Targeted immunotherapy and checkpoint blockade in children, adolescents, and young adults with lymphoma: RADICAL hodgkin cohort
by: Matthew Barth, et al.
Published: (2023-11-01)

Composite lymphoma associating diffuse large B‐cell lymphoma with classical Hodgkin lymphoma
by: Maïlis Lauwers, et al.
Published: (2022-11-01)

Treatment patterns and outcomes in adolescents and young adults with Hodgkin lymphoma in pediatric versus adult centers: An IMPACT Cohort Study
by: Sumit Gupta, et al.
Published: (2020-10-01)

Conditional Survival and Annual Hazard Estimates of Classical Hodgkin Lymphoma
by: Nuersulitan R, et al.
Published: (2021-08-01)

P018 (0139) GATA3 EXPRESSION DISTINGUISHES CLASSIC HODGKIN LYMPHOMA FROM NODULAR LYMPHOCYTE HODGKIN LYMPHOMA
Published: (2018-10-01)